Dietary Habits — Impact of Sugar-Sweetened Beverage Health Warnings
Citation(s)
Bollard T, Maubach N, Walker N, Ni Mhurchu C Effects of plain packaging, warning labels, and taxes on young people's predicted sugar-sweetened beverage preferences: an experimental study. Int J Behav Nutr Phys Act. 2016 Sep 1;13(1):95. doi: 10.1186/s12966-016-0421-7.
Fathelrahman AI, Omar M, Awang R, Cummings KM, Borland R, Bin Mohd Samin AS Impact of the new Malaysian cigarette pack warnings on smokers' awareness of health risks and interest in quitting smoking. Int J Environ Res Public Health. 2010 Nov;7(11):4089-99. doi: 10.3390/ijerph7114089. Epub 2010 Nov 22.
Klein WM, Zajac LE, Monin MM Worry as a moderator of the association between risk perceptions and quitting intentions in young adult and adult smokers. Ann Behav Med. 2009 Dec;38(3):256-61. doi: 10.1007/s12160-009-9143-2.
Moodie C, MacKintosh AM, Hammond D Adolescents' response to text-only tobacco health warnings: results from the 2008 UK Youth Tobacco Policy Survey. Eur J Public Health. 2010 Aug;20(4):463-9. doi: 10.1093/eurpub/ckp199. Epub 2009 Dec 3.
Nonnemaker, J , Farrelly, M., Kamyab, K., Busey, A., & Mann, N. (2010). Experimental study of graphic cigarette warning labels. Final Results Report. RTI Project, 7. Accessed March 20, 2018. Available at: http://www.tobaccolabels.ca/wp/wp-content/uploads/2013/12/USA-2010-Experimental-Study-of-Graphic-Cigarette-Warning-Labels-Final-Results-Report-and-Appendices-FDA.pdf
Roberto CA, Wong D, Musicus A, Hammond D The Influence of Sugar-Sweetened Beverage Health Warning Labels on Parents' Choices. Pediatrics. 2016 Feb;137(2):e20153185. doi: 10.1542/peds.2015-3185. Epub 2016 Jan 14.
Zoellner J, Estabrooks PA, Davy BM, Chen YC, You W Exploring the theory of planned behavior to explain sugar-sweetened beverage consumption. J Nutr Educ Behav. 2012 Mar-Apr;44(2):172-7. doi: 10.1016/j.jneb.2011.06.010. Epub 2011 Dec 8.
A Randomized Controlled Trial Evaluating the Impact of Sugar-Sweetened Beverage Health Warnings on Purchases
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
